MSD Animal Health Innovation GmbH, Zur Propstei, 55270, Schwabenheim, Germany.
Clinvet International Pty (Ltd), Uitsigweg, Bainsvlei, 9338, Bloemfontein, Free State, South Africa.
Parasit Vectors. 2017 Jan 16;10(1):30. doi: 10.1186/s13071-016-1954-y.
The efficacy of fluralaner for the treatment of Otodectes cynotis infestations in dogs and cats was evaluated after oral (dogs) or topical administration (dogs and cats). Twenty-four dogs and sixteen cats were experimentally infested with O. cynotis and randomly allocated to equal sized groups (n = 8/group). Dog groups were treated once, either orally with fluralaner at a minimum dose of 25 mg/kg body weight, topically with fluralaner at a dose of 25 mg/kg body weight or topically with saline solution (control). Cat groups were treated once, either topically with fluralaner at a dose of 40 mg/kg body weight or topically with saline solution. Ears of all animals were examined otoscopically for live visible mites and the amount of debris and cerumen before, and 14 and 28 days after treatment. Twenty-eight days after treatment, animals were sedated and both ears were flushed to obtain the total number of live mites per animal. The efficacy was calculated, based on the results of the ear flushing, by comparing mean live mite counts in the fluralaner treated groups versus the saline solution treated group.
A single topical treatment of cats with fluralaner reduced the mean mite counts by 100% (P < 0.001) at 28 days after treatment. Similarly, a single oral or topical treatment of dogs with fluralaner reduced the mean mite counts by 99.8% (P < 0.001) at 28 days after treatment. Cats treated topically with fluralaner had no mites visible during otoscopic examination at either 14 or 28 days after treatment. All dogs treated orally or topically with fluralaner had no mites visible during otoscopic examination at 28 days after treatment. At 14 days after treatment, only 1-2 mites were visible in three dogs (oral treatment: 2 dogs, topical treatment: 1 dog). All fluralaner-treated animals showed improvement in the amount of cerumen exudation compared with observations performed before treatment. No treatment related adverse events were observed in any dogs or cats enrolled in these studies.
In this study, fluralaner administered topically to cats and orally or topically to dogs was highly effective against Otodectes cynotis mite infestations.
本研究评估了氟雷拉纳(fluralaner)经口服(犬)或局部(犬和猫)给药治疗耳痒螨(Otodectes cynotis)感染的疗效。24 只犬和 16 只猫经实验性感染耳痒螨,并随机分为相等大小的组(n=8/组)。犬组单次治疗,口服氟雷拉纳最低剂量 25mg/kg 体重,或局部使用氟雷拉纳 25mg/kg 体重,或局部使用生理盐水(对照)。猫组单次治疗,局部使用氟雷拉纳 40mg/kg 体重或局部使用生理盐水。在治疗前、治疗后 14 天和 28 天,所有动物均行耳镜检查以评估活螨可见度、碎屑和耳垢量。治疗后 28 天,动物被镇静,并对双耳进行冲洗以获得每只动物的活螨总数。根据耳部冲洗结果,通过比较氟雷拉纳治疗组与生理盐水治疗组的平均活螨计数来计算疗效。
猫单次局部使用氟雷拉纳治疗,在治疗后 28 天可将平均螨计数降低 100%(P<0.001)。同样,犬单次口服或局部使用氟雷拉纳治疗,在治疗后 28 天可将平均螨计数降低 99.8%(P<0.001)。治疗后 14 天和 28 天,猫经局部用氟雷拉纳治疗,行耳镜检查时均未见活螨。治疗后 28 天,所有犬经口服或局部用氟雷拉纳治疗,行耳镜检查时均未见活螨。治疗后 14 天,3 只犬(口服治疗:2 只,局部治疗:1 只)可见 1-2 只活螨。与治疗前相比,所有接受氟雷拉纳治疗的动物的耳垢渗出量均有所改善。在这些研究中,未观察到与治疗相关的不良反应。
在本研究中,猫经局部用氟雷拉纳、犬经口服或局部用氟雷拉纳治疗对耳痒螨感染均高度有效。